January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Saillant Therapeutics BV
Small molecule in the GLP tox phase against a new mechanism inducing tissue regeneration in heart failure (HFrEF and HFpEF), kidney failure, neurodegenerative diseases, fibrosis, diabetes.